HumjimPiang8
2021-10-20
thanks for sharing
Why Tilray Stock Climbed More Than 14% Tuesday<blockquote>为什么Tilray股价周二上涨超过14%</blockquote>
免责声明:上述内容仅代表发帖人个人观点,不构成本平台的任何投资建议。
分享至
微信
复制链接
精彩评论
我们需要你的真知灼见来填补这片空白
打开APP,发表看法
APP内打开
发表看法
1
5
{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":859430881,"tweetId":"859430881","gmtCreate":1634719737201,"gmtModify":1634719737321,"author":{"id":3555385471829073,"idStr":"3555385471829073","authorId":3555385471829073,"authorIdStr":"3555385471829073","name":"HumjimPiang8","avatar":"https://static.tigerbbs.com/f7ab83fa2cfc43af0bc458b43eca1ebb","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":11,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":11,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p>thanks for sharing</p></body></html>","htmlText":"<html><head></head><body><p>thanks for sharing</p></body></html>","text":"thanks for sharing","highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/859430881","repostId":1155314040,"repostType":4,"repost":{"id":"1155314040","kind":"news","pubTimestamp":1634718753,"share":"https://www.laohu8.com/m/news/1155314040?lang=zh_CN&edition=full","pubTime":"2021-10-20 16:32","market":"us","language":"en","title":"Why Tilray Stock Climbed More Than 14% Tuesday<blockquote>为什么Tilray股价周二上涨超过14%</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1155314040","media":"Motley Fool","summary":"The Canadian cannabis retailer made a big leadership move and saw its stock rise the most in one day","content":"<p> <b>The Canadian cannabis retailer made a big leadership move and saw its stock rise the most in one day since mid-July.</b> <b>Key Points</b></p><p><blockquote><b>这家加拿大大麻零售商做出了重大领导层变动,其股价创下7月中旬以来的最大单日涨幅。</b><b>要点</b></blockquote></p><p> <ul> <li>Tilray added a new president.</li> <li>The meme-stock favorite has been volatile.</li> </ul> <b>What happened</b></p><p><blockquote><ul><li>Tilray增加了一位新总裁。</li><li>最受欢迎的模因股票一直不稳定。</li></ul><b>发生了什么</b></blockquote></p><p> <b>Tilray</b>(NASDAQ:TLRY)stock climbed more than 14% on Tuesday. The Canadian cannabis company opened at $10.17, then rose to as high as $11.63 during the day. The stock was as high as $63.91 in February, but has been on a steady decline since.</p><p><blockquote><b>蒂尔雷</b>(纳斯达克:TLRY)股价周二上涨超过14%。这家加拿大大麻公司开盘价为10.17美元,随后盘中最高升至11.63美元。该股2月份曾高达63.91美元,但此后一直稳步下跌。</blockquote></p><p> <b>So what</b></p><p><blockquote><b>那又怎样</b></blockquote></p><p> Tilray shook up its management team on Tuesday, appointing former Bacardi executive Blair MacNeil as the company's president. According to Tilray, MacNeil will oversee sales, marketing, and operations for Tilray's medical and adult-use cannabis business.</p><p><blockquote>Tilray周二改组了管理团队,任命前百加得高管布莱尔·麦克尼尔(Blair MacNeil)为公司总裁。据Tilray称,麦克尼尔将监督Tilray医用和成人用大麻业务的销售、营销和运营。</blockquote></p><p> Tilrayhas been active in acquisitions, with an eye toward moving into the U.S. market, once that is allowed. In May, it completed its merger with another Canadian cannabis company, Aphria, one of the biggest moves by a cannabis company this year. In August, the company purchased a majority position of outstanding senior secured convertible notes in troubled cannabis company<b>MedMen Enterprises</b>, which has 24 retail locations through six U.S. states. Tilray already owns Sweetwater Brewing and MacNeil's expertise in the beverage industry will help Tilray in the cannabis-infused beverage market.</p><p><blockquote>Tilray一直积极参与收购,着眼于一旦获得许可就进入美国市场。5月,它完成了与另一家加拿大大麻公司Aphria的合并,这是今年大麻公司最大的举措之一。8月,该公司购买了陷入困境的大麻公司已发行高级担保可转换票据的大部分头寸<b>MedMen企业</b>该公司在美国六个州拥有24个零售点。Tilray已经拥有Sweetwater Brewing,MacNeil在饮料行业的专业知识将帮助Tilray进入大麻饮料市场。</blockquote></p><p> Another factor in Tilray's rise on Tuesday was that it was a good day for several cannabis companies, and Tilray, long a meme favorite, was buoyed when it appeared the slump of cannabis stocks might be ending.<b>Canopy Growth</b> and<b>Cronos Group</b>were both up more than 7% on the day and the<b>ETFMG AlternativeHarvest ETF</b>was up more than 5%.</p><p><blockquote>Tilray周二上涨的另一个因素是,对于几家大麻公司来说,这是美好的一天,而长期以来备受迷因喜爱的Tilray在大麻股票的暴跌似乎可能结束时受到了提振。<b>冠层生长</b>和<b>克罗诺斯集团</b>当日涨幅均超过7%<b>ETFMG另类嘉实ETF</b>涨幅超过5%。</blockquote></p><p> <b>Now what</b></p><p><blockquote><b>现在怎么办</b></blockquote></p><p> It remains to be seen how long Tilray can rally. Thecannabis stockhas been highly volatile -- with its 52-week high at $67 and its 52-week low at $5.25. The company isn't showing a net profit and it reported a $34.6 million loss in the company's fiscal 2022 first-quarter report. However, it was also the company's tenth consecutive quarter of positive adjustedEBITDAand net revenue was reported as $168 million, up 43% year over year.</p><p><blockquote>Tilray能反弹多久还有待观察。大麻股票波动很大,52周高点为67美元,52周低点为5.25美元。该公司没有公布净利润,并在2022财年第一季度报告中报告亏损3460万美元。然而,这也是该公司连续第十个季度调整后债务为正,净收入为1.68亿美元,同比增长43%。</blockquote></p><p> While Tilray has been a retail investor favorite, it appears to be likely a better play as a long-term buy. The company is making aggressive moves to position itself to be a bigger player in the United States if federal laws are relaxed regarding cannabis.</p><p><blockquote>虽然Tilray一直是散户投资者的最爱,但作为长期买入,它似乎可能是更好的选择。如果联邦法律放宽有关大麻的规定,该公司正在采取积极措施,将自己定位为美国更大的参与者。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why Tilray Stock Climbed More Than 14% Tuesday<blockquote>为什么Tilray股价周二上涨超过14%</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy Tilray Stock Climbed More Than 14% Tuesday<blockquote>为什么Tilray股价周二上涨超过14%</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Motley Fool</strong><span class=\"h-time small\">2021-10-20 16:32</span>\n</p>\n</h4>\n</header>\n<article>\n<p> <b>The Canadian cannabis retailer made a big leadership move and saw its stock rise the most in one day since mid-July.</b> <b>Key Points</b></p><p><blockquote><b>这家加拿大大麻零售商做出了重大领导层变动,其股价创下7月中旬以来的最大单日涨幅。</b><b>要点</b></blockquote></p><p> <ul> <li>Tilray added a new president.</li> <li>The meme-stock favorite has been volatile.</li> </ul> <b>What happened</b></p><p><blockquote><ul><li>Tilray增加了一位新总裁。</li><li>最受欢迎的模因股票一直不稳定。</li></ul><b>发生了什么</b></blockquote></p><p> <b>Tilray</b>(NASDAQ:TLRY)stock climbed more than 14% on Tuesday. The Canadian cannabis company opened at $10.17, then rose to as high as $11.63 during the day. The stock was as high as $63.91 in February, but has been on a steady decline since.</p><p><blockquote><b>蒂尔雷</b>(纳斯达克:TLRY)股价周二上涨超过14%。这家加拿大大麻公司开盘价为10.17美元,随后盘中最高升至11.63美元。该股2月份曾高达63.91美元,但此后一直稳步下跌。</blockquote></p><p> <b>So what</b></p><p><blockquote><b>那又怎样</b></blockquote></p><p> Tilray shook up its management team on Tuesday, appointing former Bacardi executive Blair MacNeil as the company's president. According to Tilray, MacNeil will oversee sales, marketing, and operations for Tilray's medical and adult-use cannabis business.</p><p><blockquote>Tilray周二改组了管理团队,任命前百加得高管布莱尔·麦克尼尔(Blair MacNeil)为公司总裁。据Tilray称,麦克尼尔将监督Tilray医用和成人用大麻业务的销售、营销和运营。</blockquote></p><p> Tilrayhas been active in acquisitions, with an eye toward moving into the U.S. market, once that is allowed. In May, it completed its merger with another Canadian cannabis company, Aphria, one of the biggest moves by a cannabis company this year. In August, the company purchased a majority position of outstanding senior secured convertible notes in troubled cannabis company<b>MedMen Enterprises</b>, which has 24 retail locations through six U.S. states. Tilray already owns Sweetwater Brewing and MacNeil's expertise in the beverage industry will help Tilray in the cannabis-infused beverage market.</p><p><blockquote>Tilray一直积极参与收购,着眼于一旦获得许可就进入美国市场。5月,它完成了与另一家加拿大大麻公司Aphria的合并,这是今年大麻公司最大的举措之一。8月,该公司购买了陷入困境的大麻公司已发行高级担保可转换票据的大部分头寸<b>MedMen企业</b>该公司在美国六个州拥有24个零售点。Tilray已经拥有Sweetwater Brewing,MacNeil在饮料行业的专业知识将帮助Tilray进入大麻饮料市场。</blockquote></p><p> Another factor in Tilray's rise on Tuesday was that it was a good day for several cannabis companies, and Tilray, long a meme favorite, was buoyed when it appeared the slump of cannabis stocks might be ending.<b>Canopy Growth</b> and<b>Cronos Group</b>were both up more than 7% on the day and the<b>ETFMG AlternativeHarvest ETF</b>was up more than 5%.</p><p><blockquote>Tilray周二上涨的另一个因素是,对于几家大麻公司来说,这是美好的一天,而长期以来备受迷因喜爱的Tilray在大麻股票的暴跌似乎可能结束时受到了提振。<b>冠层生长</b>和<b>克罗诺斯集团</b>当日涨幅均超过7%<b>ETFMG另类嘉实ETF</b>涨幅超过5%。</blockquote></p><p> <b>Now what</b></p><p><blockquote><b>现在怎么办</b></blockquote></p><p> It remains to be seen how long Tilray can rally. Thecannabis stockhas been highly volatile -- with its 52-week high at $67 and its 52-week low at $5.25. The company isn't showing a net profit and it reported a $34.6 million loss in the company's fiscal 2022 first-quarter report. However, it was also the company's tenth consecutive quarter of positive adjustedEBITDAand net revenue was reported as $168 million, up 43% year over year.</p><p><blockquote>Tilray能反弹多久还有待观察。大麻股票波动很大,52周高点为67美元,52周低点为5.25美元。该公司没有公布净利润,并在2022财年第一季度报告中报告亏损3460万美元。然而,这也是该公司连续第十个季度调整后债务为正,净收入为1.68亿美元,同比增长43%。</blockquote></p><p> While Tilray has been a retail investor favorite, it appears to be likely a better play as a long-term buy. The company is making aggressive moves to position itself to be a bigger player in the United States if federal laws are relaxed regarding cannabis.</p><p><blockquote>虽然Tilray一直是散户投资者的最爱,但作为长期买入,它似乎可能是更好的选择。如果联邦法律放宽有关大麻的规定,该公司正在采取积极措施,将自己定位为美国更大的参与者。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源:<a href=\"https://www.fool.com/investing/2021/10/19/why-tilray-stock-climbed-more-than-14-tuesday/\">Motley Fool</a></p>\n<p>为提升您的阅读体验,我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TLRY":"Tilray Inc."},"source_url":"https://www.fool.com/investing/2021/10/19/why-tilray-stock-climbed-more-than-14-tuesday/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1155314040","content_text":"The Canadian cannabis retailer made a big leadership move and saw its stock rise the most in one day since mid-July.\n\nKey Points\n\nTilray added a new president.\nThe meme-stock favorite has been volatile.\n\nWhat happened\nTilray(NASDAQ:TLRY)stock climbed more than 14% on Tuesday. The Canadian cannabis company opened at $10.17, then rose to as high as $11.63 during the day. The stock was as high as $63.91 in February, but has been on a steady decline since.\nSo what\nTilray shook up its management team on Tuesday, appointing former Bacardi executive Blair MacNeil as the company's president. According to Tilray, MacNeil will oversee sales, marketing, and operations for Tilray's medical and adult-use cannabis business.\nTilrayhas been active in acquisitions, with an eye toward moving into the U.S. market, once that is allowed. In May, it completed its merger with another Canadian cannabis company, Aphria, one of the biggest moves by a cannabis company this year. In August, the company purchased a majority position of outstanding senior secured convertible notes in troubled cannabis companyMedMen Enterprises, which has 24 retail locations through six U.S. states. Tilray already owns Sweetwater Brewing and MacNeil's expertise in the beverage industry will help Tilray in the cannabis-infused beverage market.\nAnother factor in Tilray's rise on Tuesday was that it was a good day for several cannabis companies, and Tilray, long a meme favorite, was buoyed when it appeared the slump of cannabis stocks might be ending.Canopy Growth andCronos Groupwere both up more than 7% on the day and theETFMG AlternativeHarvest ETFwas up more than 5%.\nNow what\nIt remains to be seen how long Tilray can rally. Thecannabis stockhas been highly volatile -- with its 52-week high at $67 and its 52-week low at $5.25. The company isn't showing a net profit and it reported a $34.6 million loss in the company's fiscal 2022 first-quarter report. However, it was also the company's tenth consecutive quarter of positive adjustedEBITDAand net revenue was reported as $168 million, up 43% year over year.\nWhile Tilray has been a retail investor favorite, it appears to be likely a better play as a long-term buy. The company is making aggressive moves to position itself to be a bigger player in the United States if federal laws are relaxed regarding cannabis.","news_type":1,"symbols_score_info":{"TLRY":0.9}},"isVote":1,"tweetType":1,"viewCount":369,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":16,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/859430881"}
精彩评论